Page not found

Search results

  1. Tech Connect, Vol. 7, Issue 10: CTTC sponsors Flash Pitch '16

    ... of the activity that has taken place in our office over the past few weeks.   ...

    steelmk - 07/21/2017 - 3:04pm

  2. Tech Connect, Vol. 7, Issue 22: Forum highlights innovative approaches to bolstering biomedical research

    ... of the activity that has taken place in our office over the past few weeks.   ...

    steelmk - 07/21/2017 - 3:39pm

  3. Tech Connect, Vol. 6, Issue 16: CTTC participates at AUTM 2016

    ... of the activity that has taken place in our office over the past few weeks.    Met with Dan Arteaga, a medical ...

    steelmk - 11/10/2016 - 7:45am

  4. Tech Connect, Vol. 6, Issue 19: Vanderbilt signs license agreement with student startup Metalytics LLC

    ... of the activity that has taken place in our office over the past few weeks.    Met with the ...

    steelmk - 11/10/2016 - 7:45am

  5. Tech Connect, Vol. 7, Issue 18: Vanderbilt Vaccine Center antibody effectively treats Marburg virus in monkeys

    ... of the activity that has taken place in our office over the past few weeks.   ...

    steelmk - 07/21/2017 - 3:31pm

  6. Vanderbilt investigators lead effort to create map of the human kidney

    ... But “I’m not finished yet,” he said. “I’m past the point where many people hang up their guns, but now I’m just ...

    sommers - 11/05/2019 - 8:39am

  7. Study tracks incidence, timing of immunotherapy-related deaths

    ... to date. They determined that although these severe events can happen, the risks are “within or well below” fatality rates for ...

    sommers - 02/21/2019 - 9:51am

  8. CHARGE

    ... Jumpstart Foundry will be producing a series of conference events in the US in 2014/2015 designed to showcase the challenges and journey ...

    utleytj - 10/02/2015 - 10:45am

  9. BIO 2015 Conference

    ... with many other industry-leading investor and partnering events held around the world. In addition, we produce BIOtechNOW, an online ...

    utleytj - 10/02/2015 - 10:45am

  10. La Jolla Pharmaceutical Company and Vanderbilt University Enter Exclusive Research and License Agreement Covering Novel BMP Type-I Receptor Inhibitors

    ... Reform Act of 1995. These statements relate to future events or the Company’s future results of operations. These statements are ...

    steelmk - 10/02/2015 - 10:45am